撤机患者连续无创PCO2监测:经皮优于呼气末
本研究在有创机械通气撤机患者中比较动脉血二氧化碳分压(PaCO2)与呼气末二氧化碳分压(PetCO2)及经皮二氧化碳分压(PtcCO2)的一致性。60例患者(慢阻肺30例、非慢阻肺30例)完成方案,PtcCO2与PaCO2平均差为-0.7±3.6 mmHg,PetCO2与PaCO2平均差为-5.9±5.3 mmHg,慢阻肺患者中PetCO2低估更明显。结论支持PtcCO2用于有创机械通气患者的PCO2监测,而PetCO2明显低估PaCO2。
要点
- PtcCO2与PaCO2平均差-0.7 mmHg,一致性在临床可接受范围。
- PetCO2与PaCO2平均差-5.9 mmHg,明显低估PaCO2。
- 慢阻肺患者中PetCO2低估PaCO2最为明显。
核心结论
- PtcCO2可作为有创机械通气患者监测PCO2的合适手段。
- PetCO2明显低估PaCO2,尤其在慢阻肺患者中。
研究设计与样本
- 方法学比较研究,比较PaCO2与PetCO2及PtcCO2的一致性。
- 对象为经气管套管接受有创机械通气的撤机患者。
- 共60例患者完成方案,慢阻肺30例、非慢阻肺30例。
- PetCO2和PtcCO2连续记录,PaCO2在基线、30分钟和60分钟时分析。
- 采用Bland-Altman分析,临床可接受范围定义为平均差±4 mmHg。
主要发现
- 平均PCO2值:PaCO2 42.4±8.6 mmHg,PetCO2 36.5±7.5 mmHg,PtcCO2 41.7±8.7 mmHg。
- PtcCO2与PaCO2平均差-0.7±3.6 mmHg(95%CI:-1.6/0.3 mmHg;95%一致性限:-7.8至6.4 mmHg)。
- PetCO2与PaCO2平均差-5.9±5.3 mmHg(95%CI:-7.2/-4.5 mmHg;95%一致性限:-16.2至4.5 mmHg)。
- 慢阻肺患者中PetCO2对PaCO2的低估最为明显。
关键数值与推荐
- 临床可接受范围定义为PaCO2与非无创策略平均差±4 mmHg。
- PtcCO2与PaCO2平均差-0.7±3.6 mmHg,95%一致性限-7.8至6.4 mmHg。
- PetCO2与PaCO2平均差-5.9±5.3 mmHg,95%一致性限-16.2至4.5 mmHg。
临床怎么用
- 在有创机械通气撤机患者中可优先考虑PtcCO2连续监测PCO2。
- 使用PetCO2监测时需警惕其对PaCO2的低估,慢阻肺患者尤甚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Continuous partial pressure of carbon dioxide (PCO2 ) assessment is essential for the success of mechanical ventilation (MV). Non-invasive end-tidal PCO2 (PetCO2 ) and transcutaneous PCO2 (PtcCO2 ) measurements serve as alternatives to the gold standard arterial PCO2 (PaCO2 ) method, but their eligibility in critical care is unclear. METHODS: The present study therefore performed methodological comparisons of PaCO2 versus PetCO2 and PtcCO2 , respectively, in weaning patients receiving invasive MV via tracheal cannulas. PetCO2 and PtcCO2 were recorded continuously, while PaCO2 was analysed at baseline, and after 30 and 60 min. Using the Bland-Altman analysis, a clinically acceptable range was defined as a mean difference of ±4 mm Hg between PaCO2 and non-invasive strategies. RESULTS: A total of 60 patients (COPD (n = 30) and non-COPD (n = 30)) completed the protocol. Mean PCO2 values were 42.4 ± 8.6 mm Hg (PaCO2 ), 36.5 ± 7.5 mm Hg (PetCO2 ) and 41.7 ± 8.7 mm Hg (PtcCO2 ). Mean differences between PtcCO2 and PaCO2 were -0.7 ± 3.6 mm Hg (95% CI: -1.6/0.3 mm Hg; 95% limits of agreement: -7.8 to 6.4 mm Hg), and between PetCO2 and PaCO2 -5.9 ± 5.3 mm Hg (95% CI: -7.2/-4.5 mm Hg; 95% limits of agreement: -16.2 to 4.5 mm Hg). Underestimation of PaCO2 by PetCO2 was most pronounced in COPD patients. CONCLUSION: Our data therefore support PtcCO2 as a suitable means for monitoring PCO2 in patients undergoing invasive MV. This is in contrast to PetCO2 , which clearly underestimated PaCO2 , especially in patients with COPD.
引用
- Schwarz SB, Windisch W, Magnet FS, et al. Continuous non-invasive PCO2 monitoring in weaning patients: Transcutaneous is advantageous over end-tidal PCO2. Respirology. 2017. PMID: 28613389. doi:10.1111/resp.13095
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。